| |
Onset (days)
|
CHD
|
Maximum HR (bpm)
|
Symptoms
|
Maintenance therapy
|
Time to CV (days)
|
|---|
|
1
|
Fetal
| |
240
|
Minor
|
Flecainide + nadolol
|
40
|
|
2
|
Fetal
| |
220
|
Minor
|
Flecainide + sotalol
|
22
|
|
3
|
285
| |
280
|
Minor
|
Flecainide + sotalol
|
20
|
|
4
|
2
|
VSD + NCLV
|
210
|
Minor
|
Amiodarone + nadolol
|
40
|
|
5
|
303
| |
300
|
Shock
|
Flecainide + nadolol
|
23
|
|
6
|
36
|
VSD
|
180
|
HF
|
Flecainide + nadolol
|
22
|
|
7
|
1
| |
240
|
HF
|
Flecainide + sotalol
|
32
|
|
8
|
13
| |
230
|
Minor
|
Nadolol
|
6
|
|
9
|
1
| |
195
|
Minor
|
Propranolol
|
26
|
|
10
|
6
|
VSD
|
250
|
Minor
|
Sotalol
|
10
|
- CHD congenital heart diseases, CV cardioversion, HF heart failure, HR heart rates, minor minor symptoms, NCLV non-compacted left ventricular, VSD ventricular septal defect
